The Canadian Breast Cancer Symposium 2023 Meeting Report

TL;DR

This report summarizes the 2023 Canadian Breast Cancer Symposium, which brought together experts and patients to discuss advances in breast cancer care and research.

Contribution

The paper provides a comprehensive summary of key discussions and updates from a major national breast cancer symposium in Canada.

Findings

Sessions covered topics like AI in breast cancer and updates in systemic therapy.

The symposium emphasized collaboration and personalized approaches to breast cancer management.

Key takeaways included insights on survivorship and toxicity management of new treatments.

Abstract

On 15–16 June 2023, healthcare professionals and breast cancer patients and advocates from across Canada met in Toronto, Ontario, for the 2023 Canadian Breast Cancer Symposium (CBSC.). The CBSC. is a national, multidisciplinary event that occurs every 2 years with the goal of developing a personalized approach to the management of breast cancer in Canada. Experts provided state-of-the-art information to help optimally manage breast cancer patients, including etiology, prevention, diagnosis, experimental biology, and therapy of breast cancer and premalignant breast disease. The symposium also had the objectives of increasing communication and collaboration among breast cancer healthcare providers nationwide and providing a comprehensive and real-life review of the many facets of breast cancer. The sessions covered the patient voice, the top breast cancer papers from different disciplines in 2022, artificial intelligence in breast cancer, systemic therapy updates, the management of central nervous system metastases, multidisciplinary management of ductal carcinoma in situ, special populations, optimization-based individual prognostic factors, toxicity management of novel therapeutics, survivorship, and updates in surgical oncology. The key takeaways of these sessions have been summarized in this conference report.